certain applications including interaction mapping 10 , but there are limits to the direct applicability of these collections. The collections vary dramatically in terms of gene representation, format and functionality, as well as quality measures such as the extent of clonality, sequence annotation and experimental validation ( Supplementary Table 1 ). Tellingly, gain-of-function screening now lags behind the use of RNA interference.
Here we report the creation and characterization of two publicly available genome-scale human ORFeome collections: the human ORFeome version 8.1 Entry clone collection (hORFeome V8.1) and the Center for Cancer Systems Biology (CCSB)-Broad lentiviral expression library. Together, these collections are (i) extensive, comprising 16,172 distinct ORFs mapping to 13,833 genes, (ii) clonal and sequenced, as each ORF plasmid is derived from a single bacterial colony and nearly all clones are fully sequenced, (iii) versatile, owing to the use of Gateway (Invitrogen) recombinational cloning 11, 12 , (iv) enabling of cell-based functional screens, as the expression library encodes these clones in a lentiviral expression vector that produces consistent titers and gene expression, and permits delivery to most cell types, and (v) available via the ORFeome collaboration (Supplementary Note 1) .
We assembled these collections in four phases: first, we expanded our previous collections to 19, 281 ORFs in polyclonal format largely using existing protocols 4, 5 ; second, we derived clonal plasmid isolates from single bacterial colonies; third, we sequenced these clonal isolates and used the sequence data to choose clones for inclusion in hORFeome V8.1; and fourth, we transferred clones to a lentiviral expression vector to create the CCSB-Broad lentiviral expression library.
We expanded our library by transferring recently available ORFs from Mammalian Gene Collection (MGC) 9 cDNAs into the Gateway system using directed PCR 4, 5 to create Entry vector clones while removing stop codons ( Fig. 1a) . To maximize throughput during this initial phase, we represented clones as a nonclonal pool of bacteria derived from recombinational cloning of PCR products. We next resolved this polyclonal library into clonal isolates using a robust and efficient workflow ( Fig. 1a) in which we isolated two colonies per ORF bacterial stock (Online Methods and Supplementary Note 2) from which we prepared ORF templates for sequencing.
We developed an optimized process to leverage next-generation sequencing and efficient alignment algorithms 13 to sequence large a public genome-scale lentiviral expression library of human orfs functional characterization of the human genome requires tools for systematically modulating gene expression in both loss-of-function and gain-of-function experiments. We describe the production of a sequence-confirmed, clonal collection of over 16 ,100 human open-reading frames (orfs) encoded in a versatile Gateway vector system. using this orfeome resource, we created a genome-scale expression collection in a lentiviral vector, thereby enabling both targeted experiments and high-throughput screens in diverse cell types.
Whereas recent technological advances provide the means to efficiently scan the human genome to identify genes associated with diseases 1,2 , the subsequent functional characterization of these genes is a bottleneck in translating these discoveries into mechanistic insights and ultimately into therapeutics. Genome-scale RNA interference reagents have recently been created to enable systematic loss-of-function mammalian genomics 3 . To perform complementary gain-of-function studies, comparable libraries of arrayed cDNAs or open reading frames (ORFs) are required along with efficient methods to use these reagents in cell-based assays.
We 4,5 and others [6] [7] [8] [9] have previously reported the construction of genome-scale ORFeome collections. These collections are useful templates for subcloning 9 or recombinational transfer 8 between vectors and protein production 8 , and they enable 660 | VOL.8 NO.8 | AUGUST 2011 | nature methods brief communications numbers of ORF clones at high coverage ( Fig. 1a) . We pooled clonal isolates for each ORF. Using Illumina sequencing technology, we compared efficiencies of sequencing full vectors versus purified ORF inserts only ( Supplementary  Fig. 1a ). Although purified ORF inserts yielded higher median sequence coverage, the added sample manipulation led to substantially greater coverage variability ( Supplementary Fig. 1b-g and Supplementary Table 2 ), so we proceeded to sequence pools of full Entry-clone plasmids. For some clone pools, we used a different approach in which we PCRamplified ORF sequences from individual bacterial colonies and sequenced the amplicons in a multiplexed, pooled format previously reported 14 using 454 technology. Both methods were effective at sequencing ORF clones ( Supplementary Fig. 2) , but our protocol based on Illumina technology resulted in higher yields at lower cost per attempted clone (data not shown), and we therefore used it to sequence the majority (84%) of the collection.
To assemble ORF sequences, we aligned reads from each clone pool to MGC reference sequences. We obtained adequate reads to produce full ORF alignments for >27,000 clonal isolates from 14,722 polyclonal ORFs, at the fold coverage required for accurate base calling ( Supplementary Fig. 3 ). We annotated ORF sequences for mismatches, insertions and deletions (Supplementary Tables 3 and 4). To evaluate the sequence accuracy of multiplexed Illumina and 454 sequencing combined with our automated alignment algorithms, we resequenced >121,000 nucleotides from 287 ORFs by the Sanger method and found a confirmation rate of >99.99% of nucleotides. For each original ORF stock, we selected the clonal isolate that most closely matched the MGC reference sequence for inclusion in the hORFeome V8.1 collection. We omitted 198 clones with missing start codons.
Of 14,524 retained sequenced ORFs (Fig. 1b) , 82% (12,736) either had sequence identical to the MGC reference or had one synonymous error, and these comprise the majority of the hORFeome V8.1 collection ( Fig. 1c and Supplementary Fig. 3 ).
Another component of the V8.1 collection, denoted the 'hORFeome V8.1 mutant subcollection' , consists of 1,788 ORFs that had more than one synonymous mutation, nonsynonymous mutations or other errors, and we retained these plasmids because they may prove useful in some applications. We supplemented the fully sequenced set of ORFs with 825 clones comprising the 'hORFeome V8.1 partially sequenced subcollection' , including 597 clones from our recently described subcollection of kinases and kinase-related ORFs (clonal isolates, end-read Sanger-sequenced in two directions) 15 (Supplementary Note 3) , and 228 clones that we sequenced using next-generation technology over only part of the intended MGC ORF sequences. Finally, we refer to the 823 clonal versions of isoforms that we removed before pooled sequencing as the 'hORFeome V8.1 unsequenced subcollection' . Overall, hORFeome V8.1 includes 16,172 clonal ORFs, mapping to 13,833 human genes, of which we fully sequenced 14,524 clones (90% of V8.1 clones) for 12,940 genes (94% of V8.1 genes) ( Supplementary  Fig. 3 and Supplementary Tables 3 and 4).
Next we determined which currently annotated human transcripts were represented in hORFeome V8.1. We mapped the 14,524 fully sequenced library clones to National Center for Biotechnology Information (NCBI) reference sequence (RefSeq) coding transcripts and found that 10,216 ORFs mapped with >99% homology and constitute full-length coding sequences ( Fig. 1d and Supplementary Fig. 4 ). An additional 1,545 ORFs represented partial coding sequences. The remaining 2,763 sequenced ORFs mapped to noncoding transcripts or to RefSeq transcripts with lower homology or were not found in RefSeq. 14, 524 ORFs (complete, accepted). We sequenced 198 ORFs but rejected them because of a missing start codon (complete, rejected). Another 825 ORFs obtained sequences with undetermined nucleotides (partial), and 823 isoform ORFs were made clonal but were intentionally not sequenced (not attempted). (c) Alignment of the 14,524 completely sequenced clones with MGC templates. Of these, 12,736 clones had identical sequence as templates or had one synonymous error only (perfect) and 1,788 clones had additional mutations (mutant). (d) Alignment of the 14,524 completely sequenced clones with NCBI RefSeq transcripts. Of these, 10,216 ORFs represent full-length coding sequences with >99% homology (full), 1,545 ORFs were partial-length coding sequences with >85% homology (partial) and 2,763 clones fell into other categories.
As the original MGC cDNA source templates for these clones were derived from expressed cellular transcripts, some of these non-full length clones may represent unannotated or misannotated but physiologically relevant transcripts. Indeed, incomplete knowledge of the transcriptome is a major challenge to obtaining a comprehensive ORF resource (Supplementary Note 4).
hORFeome V8.1 enables many applications as it permits rapid ORF shuttling into any Gateway-compatible expression vector. To enable large-scale screening of this collection in mammalian cells, we developed, optimized and validated a series of Gateway-compatible mammalian expression vectors (pLX series; Supplementary  Fig. 5 ) encoding many desirable elements (Online Methods). We shuttled the entire hORFeome V8.1 collection into the pLX304-Blast-V5 vector to create the CCSB-Broad lentiviral expression library (Online Methods).
We conducted a pilot experiment on 509 ORF clones to assess (i) protocols to transfer the entry library, (ii) high-throughput production of DNA and virus, and (iii) ORF expression in A549 cells ( Fig. 2 and Supplementary Figs. 6-12 ). We performed plasmid DNA production and viral packaging in 96-well format and obtained consistent DNA yields and titers averaging 2.1 × 10 6 infectious units (IU) ml −1 ( Fig. 2b and Supplementary Fig. 7a ). Titers were preserved across all ORF sizes ( Fig. 2b and Supplementary  Fig. 8a) . We assessed ORF expression via quantification of V5 epitope tag expression and observed that ~90% of ORF lentiviruses induced expression greater than 2 s.d. above the control mean ( Fig. 2a,c and Supplementary Figs. 7b, 8b and 9) .
Using the optimized protocols, we then produced the CCSB-Broad lentiviral expression library in the pLX304-Blast-V5 vector and isolated a single bacterial colony from 98.5% of reactions (15,935 total clones). To estimate the accuracy of the final collection of expression vectors, we end-read sequenced 325 colonies and confirmed 98.2% accurate transfers (Online Methods). The utility of this resource for systematic functional genomic screens in mammalian cells is illustrated by recent results from a screen of a pilot subset of this collection (597 genes), which identified new mediators of resistance to RAF inhibition in melanoma 15 . Additional pilot experiments confirmed that this resource enables other readouts including immunofluorescence (Supplementary Fig. 10) .
In summary, we described here, to our knowledge, the most fully sequenced, flexible and annotated version of the human ORFeome to date. The entire collection, comprising both source (entry) clones and lentivirus vector expression clones, is available without restriction through the ORFeome collaboration (Supplementary Note 1). We anticipate that these collections will greatly facilitate the systematic functional assessment of human genes that mediate cellular phenotypes. online methods Clone availability. All clones described in this manuscript are publicly available via members of the ORFeome collaboration (http://www.orfeomecollaboration.org/). For details, see Supplementary Note 1. For updates of the annotation of library contents, see http://www.orfeomecollaboration.org/ or http:// www.broadinstitute.org/rnai/orfs.
Initial transfer of Mammalian Gene Collection
ORFs into the Gateway system. We cloned 19,281 ORFs, initially as polyclonal PCR populations, using MGC cDNAs 9 as templates for PCRs (removing stop codons) essentially as described previously 4, 5 . Briefly, we designed primers using the automatic primer design program Oligonucleotide Selection Program (OSP) 16 whereby the gene-specific segment of the forward primer starts from the adenine of the first in-frame ATG codon of the longest open reading frame in the cDNA and the reverse primer starts from the complimentary second nucleotide of the stop codon so as to create open-form ORFs that allow subsequent generation of sequences encoding C-terminal fusion proteins. Gateway recombinational cloning was carried out as described previously 4, 5 . All nonredundant open reading frame portions of MGC cDNA clones were consolidated into a unique set arranged by ORF size. Plasmid preparations of MGC cDNAs were performed using a Qiagen Biorobot 8000. PCR was carried out in 25-µl volumes containing 1 unit of KOD Hot Start DNA polymerase (Novagen) according to manufacturer's instructions. Gateway BP reactions were performed as described previously 4,5 using 2 µl of unpurified PCR product in 10 µl final volume to shuttle clones into the pDONR223 entry vector. Escherichia coli DH5α was transformed with a 2 µl aliquot of the BP reaction, selecting for spectinomycin (50 µg ml −1 ) resistance. To generate glycerol stocks, 1.2 ml of overnight cultures were used.
Isolation of clonal constructs. To convert polyclonal versions of
Gateway-converted MGC ORFs into clonal isolates for sequencing, we developed a bacterial growth and robotic plating protocol using gridded agar plates to achieve uniform colony spacing and density so that individual colonies could be readily selected. For details, see Supplementary Note 5.
Preparation of ORF templates for sequencing. We prepared templates from individual colonies by one of two complementary methods. For 84% of the collection, we used a custom DNA preparation protocol developed at the Broad Institute to extract high-quality plasmid DNA from bacterial pellets (http:// www.broadinstitute.org/rnai/public/resources/protocols/). For the remainder of the collection, we performed PCR directly on bacterial colonies using universal vector forward and reverse primers (M13 forward and reverse primers) as previously described 14 .
Optimization of sequencing protocols. For plasmid DNA templates containing both ORF and vector sequence, we performed pilot experiments with Illumina sequencing technology to compare the efficiency of sequencing the full vectors or first digesting the ORF inserts from these vectors and sequencing only the purified inserts. Two conditions were tested, and results are shown in Supplementary Figure 1 and Supplementary Table 2 . For experimental details, see Supplementary Note 6.
Creation of template pools for sequencing. Having identified a desired target complexity of ~4,000 ORFs per sequencing reaction (Supplementary Table 2) , we divided the library into five subsets, each comprising ORF clones from 40 master 96-well plates for subsets 1-4 and 30 master plates for subset 5. For each subset, we assembled two ORF pools (one pool from the first colonies and one pool from the second colonies). Thus, a total of 10 pools were created for sequencing. In considering the subset division, we used annotated MGC template sequences to segregate the plates in such a way that minimized the presence of intra-batch isoforms (which would preclude unambiguous alignment of sequencing reads to individual clones). Eight hundred twenty three intrabatch isoform pairs remained, and one isoform from each of these pairs was not pooled for sequencing but nevertheless retained (Supplementary Fig. 3) ; these clonal isolates were designated the 'unsequenced subcollection' . Subsets 1-4 were processed by sequencing plasmid DNA pools. To ensure equal representation of each ORF isolate in the plasmid pool, we first determined DNA concentration in each well by Hoechst dye using a Biotek Synegy HT plate reader, and then normalized the DNA wells to a standardized target concentration (25 ng µl −1 ) using a Multiprobe II robot, and finally drew 10 µl from each well to make plasmid pools.
Subset 5 was sequenced from pooled PCR products derived from clonal ORF isolates as previously described 14 . The generated PCR products were pooled for sequencing, without normalization.
Sequencing of ORF clones.
A total of ten pools of clonal ORFs were sequenced. Eight ORF pools derived from subsets 1-4 were sequenced with Illumina Genome Analyzer II sequencers at the Broad Institute. In summary, the plasmid DNA pools were subjected to shearing to achieve normalized DNA fragment lengths, followed by sequencing adaptor ligation to create Illumina libraries. Illumina libraries were sequenced using standard manufacturer's protocols. Enriched libraries were quantified using standard SYBR green quantitative PCR protocols using primers specific to the Illumina paired-end adapters. Libraries were normalized to 2 nM and denatured using 0.1 N NaOH. Denatured libraries were cluster amplified on v2-v4 flowcells using v2-v4 chemistry according to manufacturer's protocol (Illumina). Flowcells were sequenced on Genome Analyzer II sequencers, using v3-v4 Sequencing-by-Synthesis kits and analyzed with the Illumina's v1.4-1.6 pipeline following manufacturer's protocol (Illumina). Unpaired reads of 76 bases were obtained for batch 1 pools and paired-end reads of 76 bases were obtained for batches 2-4.
The two ORF pools derived from subset 5 were sequenced using the 454 FLX Titanium sequencing system (454 Life Sciences, Roche) at the Dana-Farber Cancer Institute Center for Cancer Systems Biology. The pooled PCR products of the entry clones were partially purified using Qiagen MinElute PCR purification kit following the manufacturer's instructions. Approximately 5 µg of the pooled DNA was subjected to nebulization for 90 s with nitrogen gas at 30 pounds per square inch. After purification using the MineElute PCR purification kit, the sheared DNA was size-selected using AMPure beads (Agencourt). DNA fragments with the size range of 300-800 base pairs were end-repaired and processed for sequencing using the Roche Titanium Chemistry reagents and protocols.
The 597 kinase ORF clones were sequenced bi-directionally via Sanger-based sequencing at Agencourt/Beckman Coulter Genomics using vector-specific primers.
Sequence alignment. Sequencing reads that passed technologyspecific quality filters were aligned to reference sequences derived from the MGC. Alignments were performed using Burrows-Wheeler aligner-based aligners contained in the Picard toolkit developed at the Broad Institute, and a custom tool developed at the Broad Institute provided alignment information over each base. Reference files for each pool consisted of MGC template sequence with 55-base-pair vector sequences at 5′ and 3′ ORF ends to facilitate alignment of reads spanning vector and ORF junctions. ORF clones that passed empirically determined median coverage thresholds (454, median coverage ≥ 2; Illumina, mean or median coverage ≥5) were considered to have been successfully sequenced and were subjected to sequence analysis. The majority of ORF clones were sequenced at coverage far above thresholds (median coverage was 17 for 454 and 28 for Illumina). Histograms of base coverage for the five batches are shown in Supplementary Figure 2. Sequence analysis. Aligned ORF sequences were subjected to an automated mutation detection script created to assign numerical error codes (1) (2) (3) (4) (5) (6) (7) (8) (9) (10) (11) (12) (13) (14) (15) (16) (17) (18) (19) corresponding to particular categories of sequence errors (0 denotes no errors). Code descriptions are shown in Supplementary Table 3 . The script first examined mean or median coverage to allow above-threshold contigs for subsequent analysis. ORFs with mean or median coverage below these thresholds were assigned a code 18 (sequencing failure). In the cases of batches 1-4 (Illumina sequencing from plasmid DNA), the script then examined output DNA quantification files from plasmid preparations and applied a DNA quantification value threshold. ORF plasmid preparations that did not meet threshold DNA values were assigned a code 19 (DNA preparation failure). After this step, all remaining reads were parsed to determine the base call for each position. For each base position at which multiple nucleotides were observed in the aligned sequence, the number of instances (I 1 ) the most frequently observed nucleotide (N 1 ) was observed was compared to the number of instances (I 2 ) the next most frequently observed nucleotide (N 2 ) was observed. If I 1 /I 2 exceeded an empirically derived ratio, the base was annotated as N 1 . Otherwise the base was labeled as N (marking ambiguity) and error code 13 (ambiguous base call) was assigned to that ORF sequence. The script then proceeded to compare the contig sequences with MGC reference sequences to assign the rest of error codes listed in Supplementary Table 3 . hORFeome V8.1 rearray. As we sequenced two clones or colonies derived from each starting polyclonal ORF, our final step in creating hORFeome V8.1 was to select one clone per ORF to include in the final collection. In many cases, both ORF clones had sequence that perfectly matched the MGC template, and we simply included one of these isolates in hORFeome V8.1. In cases in which one ORF clone had errors and one ORF clone did not, we selected the ORF clone without errors to include in hORFeome V8.1. In cases in which both ORF clonal isolates had errors, we rearrayed the clone with the error predicted to have a lesser effect on expression or function. These selections used the numerical error codes described above with the numbering schema reflecting the relative error severity (that is clone with error 4 selected over clone with error 5 and so on). Clones in the final collection with errors greater than one synonomous mutation were denoted the 'hORFeome V8.1 mutant subcollection' . All hORFeome V8.1 entry clones are publicly available (Supplementary Note 1) .
Comparing obtained sequences to annotated RefSeq transcript sequences via Blast. The ORF sequences were searched against RefSeq by megablast (word size, 16; percentage identity cutoff, 85). The match percentage along the entire length of ORF was then computed. Of 14, 524 ORFs sequenced, 13,043 had RefSeq matches, 12,220 of which with ≥99% of its entire length matching a RefSeq transcript. Of these 12,220 highstringency matches, 10,216 ORFs included the full-length protein coding sequence. These results are shown in Figure 1b and Supplementary Figure 4 .
Expression vectors and control ORF entry vectors.
To create a custom set of Gateway-compatible lentiviral expression vectors suitable for high throughput screening with hORFeome V8.1 entry clones, we modified the pLKO.1 vector backbone 17 to add features desirable for ORF expression. Briefly, we added a PGK promoter driving a selectable marker, either BSR inducing blasticidin resistance (pLX303-Blast and pLX304-Blast-V5) or PAC inducing puromycin resistance (pLX301-Puro and pLX302-Puro-V5). We added a central polypurine tract (cPPT) element that promotes viral titer. We added a CMV promoter to drive robust ORF expression. We cloned the Gateway cassette (including CAT driving chloramphenicol resistance and the ccdB topoisomerase poison) from pLenti6.3 (Invitrogen) and inserted this sequence downstream of the CMV promoter. We cloned the V5 epitope sequence 18 in-frame downstream of the 3′ Gateway attR sequence in the cases of the pLX302-Puro-V5 and pLX304-Blast-V5 vectors. The WPRE element, which has been documented to enhance RNA expression 19 , was cloned downstream of the stop codons in these vectors. Maps of these vectors are shown in Supplementary Figure 5 . pLX301, pLX302, pLX303 and pLX304 are available via Addgene (http://www.addgene.org/). In direct comparisons these vectors produced ORF expression equivalent to the pLenti6.3 expression vector (Invitrogen), while achieving greater and more consistent plasmid DNA yields and viral titers (data not shown).
To test the pLX301, pLX302, pLX303 and pLX304 vectors, we created fully sequenced, clonal entry clone vectors with ORFs encoding either EGFP, LacZ, Luciferase (cloned from pTALluc, BD Biosciences), HCRED (BD Biosciences Living Colors series) or BFP (cloned from pRSET-BFP, Invitrogen) genes. pDONR221-EGFP, pDONR223-LUCIFERASE, pDONR223-LACZ, pDONR223-HcRED and pDONR223-BFP vectors are available via Addgene. In addition we created four vectors encoding ORFs with oncogenic mutations, which were helpful positive controls in some pilot experiments (data not shown). These include pDONR223-MEK1 DD (as previously described 15 ), plus pDONR223-KRAS V12 , pDONR223-HRAS V12 and pDONR223-BRAF E600 . These vectors are also available via Addgene. LR transfers. The transfer of ORFs from from pDONR223 entry vectors into the pLX304-Blast-V5 destination vector was carried out using LR Clonase (Invitrogen) (Supplementary Fig. 11) . A 5-µl reaction included 25 ng each of entry clone plasmid and destination vector, and 0.25 µl of LR Clonase (1/16 of a reaction unit defined by the manufacturer). The LR reaction proceeded overnight. Then 10 µl of ccdB-sensitive E. coli DH5α competent cells were then added to the entire LR reactions for heat-shock transformation. The transformants were selected with 100 µg ml −1 carbenicillin on multiwell, gridded, agar plates. These reactions are highly efficient as the unrecombined destination vector cannot be propagated in the ccdB-sensitive DH5α 11 . We obtained colonies from 98.5% of LR reactions. A single colony was isolated from each LR reaction.
CCSB-Broad lentiviral expression library. One colony was isolated for each LR reaction. Glycerol stocks, in 96-well format, were then made from the overnight cultures. To estimate the accuracy of the resulting collection, we performed end-read Sanger-based sequencing in one direction from 325 expression vectors. Sequences from 319 of 325 (98.2%) of these expression vectors correctly aligned to the corresponding entry clone from the hORFeome V8.1 entry clone collection. Thus, of the 16,172 clones in hORFeome V8.1, we obtained colonies from 15,935 (98.5%) of reactions and of these successful reactions, we estimate that 98.2% correctly recombined into expression vectors, resulting in ~15,600 accurate expression clones. All CCSB-Broad lentiviral expression library clones are publicly available (Supplementary Note 1) .
Preparation of high-titer virus. Detailed viral packaging protocols are available at http://www.broadinstitute.org/rnai/public/ resources/protocols/. Briefly, 100 ng of ORF plasmid, 100 ng of packaging plasmid (psPAX2) and 10 ng of envelope plasmid (VSV-G) were used to transfect packaging cells (293T) with TransIT-LT1 (Mirus Bio). Virus was collected 48 and 70 h after transfection. These two samples were combined.
Virus infection and titer measurement.
Detailed lentivirus infection protocols are available at http://www.broadinstitute.org/rnai/ public/resources/protocols/. Briefly, before transduction, we changed cell medium to fresh medium containing polybrene (10 µg ml −1 ). Viruses were then added and the cell plates were spun at 1,178g for 30 min. Where noted, medium containing blasticidin was added 24 h after infection for drug selection. Virus titers were determined by infecting A549 or A375 cells ( Supplementary Note 7 and Supplementary Fig. 12 ).
Li-COR and immunoblotting. An Odyssey scanner (Li-COR Biosciences) was used to detect staining of fixed cells or gel membranes incubated with appropriate antibodies ( Supplementary  Note 8 and Supplementary Fig. 12 ).
